- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT00261859
Enhancing Emergency Practitioner (EP)-Performed Alcohol Interventions in the Emergency Department (ED)
March 4, 2020 updated by: Yale University
Enhancing EP-Performed Alcohol Interventions in the ED
The purpose of this study is to evaluate the effectiveness of an enhanced emergency practitioner (EP) performed brief intervention (BI), namely, the Enhanced Brief Negotiation Interview (E-BNI).
This includes a basic BNI performed in the ED with referral to a primary care provider, followed by a telephone booster intervention performed by trained nurses 1-month post ED visit.
The E-BNI will be compared to the basic BNI (without booster), and standard care with assessments (SC-A) and without (SC-NA).
In a randomized, controlled clinical trial 900 hazardous and harmful (HH) drinkers will be randomly assigned to one of the 4 conditions.
We, the researchers at Yale University, will conduct cost benefit analysis of the interventions.
Follow-up assessments, at 6 and 12-months, will be obtained via interactive voice response (IVR).
Study Overview
Detailed Description
A critical need exists to refine and test brief interventions (BI) for Emergency Department (ED) populations with hazardous and harmful (HH) drinking that can be translated into real-world settings; and to enhance the effects of these BIs so they can be maintained over time.
The ED is an ideal setting for BIs, as many ED patients who exceed low-risk recommendations do not have contact with either alcohol treatment specialists or visit primary care medical practitioners.
This includes a large segment of young adults ages 18-30 whose only contact with the health care system is often an ED visit.
The purpose of this study is to evaluate the effectiveness of an enhanced Emergency Practitioner (EP) performed BI, namely, the Enhanced Brief Negotiation Interview (E-BNI).
This includes a basic BNI performed in the ED with referral to a primary care provider, followed by a telephone booster intervention performed by trained nurses 1-month post ED visit.
The E-BNI will be compared to the basic BNI (without booster), and standard care with assessments (SC-A) and without (SC-NA).
In a randomized, controlled clinical trial 900 HH drinkers will be randomly assigned to one of the 4 conditions.
We will conduct cost benefit analysis of the interventions.
Follow-up assessments, at 6 and 12-months, will be obtained via interactive voice response (IVR).
Study Type
Interventional
Enrollment (Actual)
900
Phase
- Phase 2
- Phase 3
Contacts and Locations
This section provides the contact details for those conducting the study, and information on where this study is being conducted.
Study Locations
-
-
Connecticut
-
New Haven, Connecticut, United States, 06510
- Yale New Haven Hospital (Adult Emergency Department)
-
-
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
18 years and older (Adult, Older Adult)
Accepts Healthy Volunteers
No
Genders Eligible for Study
All
Description
Inclusion Criteria:
- Patients, 18 years or older, who present to the adult ED at Yale-New Haven Hospital will be screened for exceeding the NIAAA criteria for low-risk drinking
- Patients may be hazardous "at-risk" drinkers who screen over the limits, but do not currently exhibit medical, social or legal problems as a result of their drinking, or they may be harmful drinkers, presenting with an alcohol associated injury or illness.
Exclusion Criteria:
Patients will be excluded for the following reasons:
- Non-English speaking;
- Alcohol dependence;
- Current enrollment in a substance abuse treatment program;
- Current ED visit for acute psychiatric complaint;
- Condition that precludes interview i.e., life threatening injury/illness;
- In police custody; or
- Inability to provide two contact numbers for follow-up.
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
- Primary Purpose: Other
- Allocation: Randomized
- Interventional Model: Factorial Assignment
- Masking: Triple
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
---|---|
No Intervention: SCA
Standard Care with Assessment
|
|
No Intervention: SCNA
Standard Care No Assessment
|
|
Experimental: BNI
Brief Negotiated Interview
|
behavioral- brief intervention
|
Experimental: EBNI
Enhanced Brief Negotiated Interview
|
behavioral- brief intervention
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Time Frame |
---|---|
efficacy of brief intervention
Time Frame: 12 months
|
12 months
|
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Sponsor
Investigators
- Principal Investigator: Gail D'Onofrio, MD, MS, Yale University
Publications and helpful links
The person responsible for entering information about the study voluntarily provides these publications. These may be about anything related to the study.
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start
October 1, 2005
Primary Completion (Actual)
November 1, 2009
Study Completion (Actual)
November 1, 2009
Study Registration Dates
First Submitted
December 2, 2005
First Submitted That Met QC Criteria
December 2, 2005
First Posted (Estimate)
December 5, 2005
Study Record Updates
Last Update Posted (Actual)
March 6, 2020
Last Update Submitted That Met QC Criteria
March 4, 2020
Last Verified
March 1, 2020
More Information
Terms related to this study
Keywords
Other Study ID Numbers
- 0303025116
- R01AA014963-01A1 (U.S. NIH Grant/Contract)
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Harmful Drinking
-
University of OsloThe Research Council of NorwayCompleted
-
University of OsloThe Research Council of NorwayCompletedHazardous Drinking | Harmful DrinkingNorway
-
Yale UniversityNational Institute on Alcohol Abuse and Alcoholism (NIAAA)CompletedHeavy Drinking | Harmful; Use, AlcoholUnited States
-
Brown UniversityNational Institute on Alcohol Abuse and Alcoholism (NIAAA)Enrolling by invitationAlcohol Drinking | Alcohol; Harmful UseUnited States
-
Daniela Romero ReyesUniversidad Nacional de Educación a DistanciaCompletedAlcohol; Harmful UseMexico
-
Yale UniversityNational Institute on Alcohol Abuse and Alcoholism (NIAAA)CompletedHazardous Drinking | Harmful DrinkingUnited States
-
University of Central FloridaEnrolling by invitationAlcohol Use, Underage | Harmful; Use, AlcoholUnited States
-
Brown UniversityCompleted
-
Women's College HospitalRecruitingAlcohol; Harmful Use | Tobacco Use | Tobacco Use Cessation | Alcohol Use, UnspecifiedCanada
-
Carnegie Mellon UniversityNational Institute on Alcohol Abuse and Alcoholism (NIAAA); University of Pittsburgh and other collaboratorsActive, not recruitingAlcohol Drinking | Alcoholism | Alcohol; Harmful Use | Binge Drinking | Alcohol Use Disorder | Alcohol IntoxicationUnited States
Clinical Trials on BNI
-
Yale UniversityCompletedSmoking | DrinkingUnited States
-
Yale UniversityNational Institute on Alcohol Abuse and Alcoholism (NIAAA)RecruitingAlcohol Use DisorderUnited States
-
Boston Medical CenterCompletedCervical Cancer | Vulvar Cancer | Anal Cancer | Vaginal Cancer | Oropharyngeal Cancer | Penile Cancer | Human Papillomavirus Infection | Human Papilloma VirusUnited States
-
Yale UniversityNational Institute on Alcohol Abuse and Alcoholism (NIAAA)CompletedAlcohol DependenceUnited States
-
Yale UniversityNational Institute on Alcohol Abuse and Alcoholism (NIAAA)CompletedHazardous Drinking | Harmful DrinkingUnited States
-
The National Center on Addiction and Substance...Patient-Centered Outcomes Research Institute; Massachusetts General Hospital; Columbia University and other collaboratorsNot yet recruitingSubstance Use
-
Center for Progressive Recovery, LLCNational Institute on Drug Abuse (NIDA); Yale UniversityNot yet recruitingCriminal Behavior | Opioid Use Disorder, Moderate | Opioid Use Disorder, Severe
-
Boston Medical CenterCompletedSexually Transmitted InfectionUnited States
-
Boston Medical CenterCompletedCervical CancerUnited States
-
Yale UniversityNational Institute on Drug Abuse (NIDA)Completed